Details for New Drug Application (NDA): 215718
✉ Email this page to a colleague
The generic ingredient in DAPSONE is dapsone. There are eight drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the dapsone profile page.
Summary for 215718
Tradename: | DAPSONE |
Applicant: | Alembic |
Ingredient: | dapsone |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 215718
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DAPSONE | dapsone | GEL;TOPICAL | 215718 | ANDA | Alembic Pharmaceuticals Inc. | 62332-663 | 62332-663-30 | 1 BOTTLE, PUMP in 1 CARTON (62332-663-30) / 30 g in 1 BOTTLE, PUMP |
DAPSONE | dapsone | GEL;TOPICAL | 215718 | ANDA | Alembic Pharmaceuticals Inc. | 62332-663 | 62332-663-60 | 1 BOTTLE, PUMP in 1 CARTON (62332-663-60) / 60 g in 1 BOTTLE, PUMP |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TOPICAL | Strength | 7.5% | ||||
Approval Date: | Oct 27, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription